Skip to content

Apotheek Dok Noord

Active Private limited companyfounded 2015active for 11 yearsDok-Noord 7, 9000 GhentKBO/BCE: BE 0635.613.482

Lifetime

10 annual accounts with figures on one time axis
peak of €291,562 in 2025
€291,562▲ 0.2%
lowest -€12,193 in 2016
€118,621▼ 1.9%
peak of €259,625 in 2022
€20,549▼ 89.6%
€401,901▲ 43.2%
peak of 1.9 FTE in 2022
1.9 FTE▲ 5.6%
Board2 names since 2015
2 directors and 1 other
Documentsfilings and deeds
15-06-202646 days before the deadline
2025abbreviated format
Dividend €291,000Equity from €197,553 to €20,549Debts from €280,619 to €401,901

Key points

from the 2025 annual accounts

Equity

€20,549 from €259,625 in 2022

Equity fell by 92% in 3 years.

Turnover

≈ €1.0m estimated

The accounts state no turnover.

Debts

€401,901 95% of the balance sheet
Suppliers 12%Taxes and wages 10%Other 78%

Of this, €395,325 falls due within a year.

Liquidity

0.91 was 1.46 in 2024

Short-term debts rose from €268,706 to €395,325.

Filings

10 annual accounts 4 late
AprilJune31 JulyOctober20202025

The 2016 accounts came in latest, 56 days after the end of the period.

Position in the sector

€20,549

Less equity than 85% of companies in retail trade. The sector median is €314,193, over 13,325 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,326 companies had the same profile as Apotheek Dok Noord has now. Each dot stands for 4 companies, two years later.

95.1%
were still trading
3.2%
stopped another way
1.5%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,326 companies, not a prediction for Apotheek Dok Noord. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 18-08-2015
Director, since 18-08-2015
  • 150 sharesdeed of 13-07-2023
  • 150 sharesdeed of 13-07-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0635613482
2 managers resigning, 2 directors reappointed (manager) and (manager) resign · (director) and (director) reappointed · 300 shares · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €6,200 paid up · Founded by and · (statutory manager) and (statutory manager) appointed · published on 20-08-2015 · Gazette deed
First establishment Dok-Noord 7, Ghent
All 18 events

Comparable companies

same main activity, similar in size and age
Company
Apotheek Dok Noord Ghent €422,450 €291,562 4.9% 1.9
APOTHEEK RABOT Ghent €467,914 €283,258 7.1% 2.4
APOTHEEK GENT - SINT-PIETERS Ghent €407,160 €275,611 -351.8% 2.1
JELY PHARMA Incourt €469,684 €253,186 0.1% 1.6
PHARMACIE VANDERVELLEN Woluwe-Saint-Lambert €439,239 €305,680 4.8% 2.6
PHARMACIE VANDECASTEELE Woluwe-Saint-Lambert €388,091 €322,062 48.8% 2.6
APOTHEEK AN LEYMAN Ghent €551,428 €291,559 74.2% 2.5

These companies have the same main activity as Apotheek Dok Noord: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €388,000 and €551,000, founded between 2011 and 2016.

Official details

Source: KBO
Status
Active since 18-08-2015Normal situation
Registered office
48 active companies are registered at this addressOf these, 3 started in the 12 months before 22 November 2026. Source: KBO register, as of 22 November 2026.
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.245.109.7389000 Ghent, since 18-08-2015
Financial year end
31 December
Peppol
Reachable since 15-09-2025
Company details

Annual accounts 2025

€422,450▼ 11.7%
Employeeson 31-12-2025
3=
Filing
Filed on 15-06-2026, 46 days before the end of the filing period
Financials

Insights on Apotheek Dok Noord

Apotheek Dok Noord files the abbreviated format. That format states no turnover. The gross margin rose from €30,962 in 2016 to €291,562 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Apotheek Dok Noord

What is the company number of Apotheek Dok Noord?
The company number of Apotheek Dok Noord is 0635.613.482. The VAT number is the same number with BE in front: BE 0635.613.482.
Where is Apotheek Dok Noord based?
The registered office is at Dok-Noord 7, 9000 Ghent.Company details
What does Apotheek Dok Noord do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Dok Noord?
Apotheek Dok Noord is a private limited company (BV).
When was Apotheek Dok Noord founded?
Apotheek Dok Noord was founded on 18-08-2015.
Is Apotheek Dok Noord still active?
Yes, Apotheek Dok Noord is an active enterprise in the KBO register.
How many employees does Apotheek Dok Noord have?
Apotheek Dok Noord had an average of 1.9 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Dok Noord?
The turnover in financial year 2025 is about €1.0m. This figure is estimated from the gross margin of €291,562 and 42 comparable companies (NACE 477). It probably lies between €790,000 and €1.4m.
Is Apotheek Dok Noord profitable?
In financial year 2025, Apotheek Dok Noord made a profit of €118,621.
Where can I find the annual accounts of Apotheek Dok Noord?
Apotheek Dok Noord filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Dok Noord due?
Apotheek Dok Noord must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.